Source: ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
Gerard Moreno, Alejandro Rodríguez, Jordi Sole-Violán, Ignacio Martín-Loeches, Emili Díaz, María Bodí, Luis F. Reyes, Josep Gómez, Juan Guardiola, Sandra Trefler, Loreto Vidaur, Elisabet Papiol, Lorenzo Socias, Carolina García-Vidal, Eudald Correig, Judith Marín-Corral, Marcos I. Restrepo, Jonathan S. Nguyen-Van-Tam, Antoni Torres. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia. ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020

Member's Comments

No comment yet.

Related content which might interest you: Risk factors and outcomes of severe influenza pneumonia with bacterial co-infection in critically ill patients Source: International Congress 2017 – Sepsis, infections, ARDS and beyond Year: 2017 Vaccination rates against pneumococcal and influenza infection in hospitalized cardiologic and pneumologic patients need to be improved. Source: International Congress 2018 – Respiratory epidemiology:  from infectious diseases to lung cancer Year: 2018 Surfactant therapy of A/H1N1 severe pneumonia and ARDS is a chance for survival Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010 The relationship between delayed anti-TB treatment and hospital mortality in critically ill patients Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Duration of therapy in hospitalised patients with CAP Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia Year: 2007 How can I prevent infectious complications in critically ill patients? Source: Annual Congress 2008 - PG13 - Respiratory failure: skills needed to treat an episode of acute respiratory failure Year: 2008 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 The impact of empiric antibacterial therapy on mortality for patients hospitalized with community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 733s Year: 2006 Treating acute complications and the severely ill patient with tuberculosis Source: International Congress 2018 – PG13 Challenges in the treatment of tuberculosis Year: 2018 Effectiveness of immune stimulatory therapy in patient with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Impact of pulmonary rehabilitation on sequelae produced in critically ill patients by COVID-19. Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19 Year: 2021 The effect of pre-hospital anti-platelet therapy in adults with ARDS: A meta-analysis Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016 Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Source: Eur Respir J 2013; 41: 123-130 Year: 2013 Clinical efficacy of moxifloxacin in severely ill patients with CAP Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 Comparison of H1N1 associated pneumonia with community acquired pneumonia in hospitalized patients Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis Year: 2010 Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections Year: 2012 Which respiratory and non–respiratory factors contribute to outcome in critically ill patients with invasive ventilation? Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients Year: 2018 Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation Source: Eur Respir J, 56 (5) 2001875; 10.1183/13993003.01875-2020 Year: 2020